BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1187 related articles for article (PubMed ID: 18985950)

  • 21. Medicare program; policy and technical changes to the Medicare Advantage and the Medicare prescription drug benefit programs. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Apr; 75(72):19677-826. PubMed ID: 20422785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions; prescription drug benefit program: payments to sponsors of retiree prescription drug plans. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Jan; 77(8):1877-83. PubMed ID: 22359793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Part I--Medicare prescription drug coverage (Part D): the promise.
    Witten B
    Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
    [No Abstract]   [Full Text] [Related]  

  • 24. Medicare and Medicaid programs; limits on payments for drugs--HCFA. Final rule.
    Fed Regist; 1987 Jul; 52(147):28648-58. PubMed ID: 10301766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare program; Medicare-Endorsed Prescription Drug Card Assistance Initiative. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2002 Sep; 67(171):56617-85. PubMed ID: 12233763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 27. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.
    Cubanski J; Neuman P
    Health Aff (Millwood); 2007; 26(1):w1-12. PubMed ID: 17118944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicare program; changes to Medicare payment for drugs and physician fee schedule payments for calendar year 2004. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Jan; 69(4):1083-267. PubMed ID: 14968797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The other drug war. Administration, HMOs playing hardball over prescription medicine benefit.
    Hallam K
    Mod Healthc; 1999 Oct; 29(40):44. PubMed ID: 10621454
    [No Abstract]   [Full Text] [Related]  

  • 30. Medicare program; e-prescribing and the prescription drug program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Nov; 70(214):67567-95. PubMed ID: 16273748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicare Program: Changes to the Medicare Claims and Entitlement, Medicare Advantage Organization Determination, and Medicare Prescription Drug Coverage Determination Appeals Procedures. Final rule.
    Centers for Medicare & Medicaid Services, HHS
    Fed Regist; 2017 Jan; 82(10):4974-5140. PubMed ID: 28102985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first months of the prescription-drug benefit--a CMS update.
    Bach PB; McClellan MB
    N Engl J Med; 2006 Jun; 354(22):2312-4. PubMed ID: 16738266
    [No Abstract]   [Full Text] [Related]  

  • 33. Medicare program; reduction in Medicare Part B premiums as additional benefits under Medicare+Choice plans. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Nov; 68(229):66721-3. PubMed ID: 14649655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicare 'mega reg' offers providers mixed bag.
    Public Sect Contract Rep; 1998 Sep; 4(9):133-5. PubMed ID: 10185349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicare program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2014 May; 79(100):29843-968. PubMed ID: 24855709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceuticals and medical devices: Medicare Part D.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844
    [No Abstract]   [Full Text] [Related]  

  • 37. Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2005. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Nov; 69(219):66235-915. PubMed ID: 15551493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicare Part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2009.
    Stubbings J; DePue RJ
    Am J Manag Care; 2009 Sep; 15(9):645-9. PubMed ID: 19747029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. House says "yes" to Medicare Part D price negotiations, passes legislation.
    Consult Pharm; 2007 Mar; 22(3):254. PubMed ID: 17691158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.